Urinary proteins from Sickle Cell patients induce inflammation and kidney injury via the TGFβ-p53 axis in a podocyte cell culture model.

wruck, w.; Pranty, A. I.; Thimm, C.; Loerch, C.; Mack, R.; Koranteng-Adjaye, T.; Boima, V.; Dei-Adomakoh, Y.; Lartey, M.; Adjaye, J.

doi:10.1101/2025.08.08.669286

bioRxiv · 10.1101/2025.08.08.669286

Urinary proteins from Sickle Cell patients induce inflammation and kidney injury via the TGFβ-p53 axis in a podocyte cell culture model.

wruck, w.·Pranty, A. I.·Thimm, C.·Loerch, C.·Mack, R.·Koranteng-Adjaye, T.·Boima, V.·Dei-Adomakoh, Y.·Lartey, M.·Adjaye, J.

View original source ↗Export metadata ↓

Abstract

BackgroundSickle cell disease (SCD) is an inherited blood disorder affecting the oxygen-carrying hemoglobin in red blood cells making them deform into a sickle shape. Hemolysis and vaso-occlusion associated with this process can lead to complications in many organs and frequently to renal complications. Numerous factors are considered to contribute towards the development of proteinuria (PU) in SCD including hyperfiltration, ischemia, oxidative stress and decreased nitric oxide (NO) bioavailability but the detailed pathophysiology still needs further elucidation. MethodsEmploying arrays, we investigated cytokines and kidney injury-associated markers in the urine of a cohort of SCD patients from Ghana carrying the SS and SC genotypes which were further sub-divided into groups with proteinuria (SCD_PU) and without proteinuria (SCD). ResultsWe identified up-and down-regulated proteins when comparing SCD with and without proteinuria. Amongst these is the well-established kidney injury marker-Clusterin which was up-regulated and could be validated in an ELISA-based assay. Refining the study to the SS and SC genotypes, we identified (and confirmed by ELISA) another established kidney injury marker-NGAL, as up-regulated in both genotypes and SCD with and without proteinuria. Metascape-based analysis of biological processes revealed "Cellular component disassembly" associated with proteins expressed in SCD but not regulated between PU and no PU and "leukocyte chemotaxis" down-regulated in SCD_PU vs. SCD. Interestingly, "Integrin-cell-surface interactions" was associated with proteins up-regulated between SCD_PU vs. SCD which is consistent with endothelial hyperplasia in the setting of glomerular hyperfiltration. To investigate the effect secreted urine proteins have on human podocytes in vitro, immortalized podocytes supplemented with SCD_PU urine showed elevated p53 levels in both immunofluorescence staining and RT-PCR compared to SCD. Additionally, RT-PCR revealed elevated levels of VEGF, NGAL and the pro-inflammatory proteins-TGF{beta}, IL6, IL8 and TNF. ConclusionWe hypothesize that the increased number of endothelial cells in hyperplasia and hyperfiltration leads to more Integrin-mediated links to podocyte foot processes at the glomerular basement membrane and to glomerular fibrosis. Severe inflammation and kidney injury in SCD_PU patients is induced by the TGF{beta}-p53 axis.

Explore related subjects

molecular biology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

wruck, w., Pranty, A. I., Thimm, C., Loerch, C., Mack, R., Koranteng-Adjaye, T., Boima, V., Dei-Adomakoh, Y., Lartey, M., Adjaye, J.. 2025-08-09. Urinary proteins from Sickle Cell patients induce inflammation and kidney injury via the TGFβ-p53 axis in a podocyte cell culture model.. https://doi.org/10.1101/2025.08.08.669286

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Engineered Miniature ParTasR Enables Efficient PAMless Genome Editing

TIGR-Tas system holds great promise for genome-engineering applications owing to its compact size and PAMless targeting capability. However, its low editing efficiency in mammalian cells severely limits its broader utility. Here, we engineered a highly active variant of ParTasR, termed eTasR, through structure-guided rational design of ParTasR combined with fusion to the exonuclease TREX2. eTasR increased mammalian editing efficiency from the original 4.29% to 48.94% with an average 26.52-fold increase, significantly surpassing the efficiency of SpRY, a reported version of PAM-free nuclease. More importantly, single-AAV delivery enabled efficient Hpd disruption in vivo, resulting in robust phenotypic rescue. Thus, eTasR provides a compact, PAMless and highly efficient platform for genome editing and therapeutic applications.

molecular biology↗

bioRxiv2026

Enhancing pancreatic islet cell survival via NMDAR antagonist-driven ROR1 activation as revealed by phosphoproteomics

NMDA receptors (NMDARs) control function and survival not only of neurons, but also of insulin-producing pancreatic beta cells. Since insufficient insulin secretion and beta cell death are key events during diabetes development, targeting NMDARs offers a therapeutic approach. Specifically, the NMDAR antagonist dextrorphan (DXO) increases glucose-stimulated insulin secretion in clinical trials. Furthermore, treatment with DXO or optimized DXO derivatives prevents pancreatic islet cell death upon diabetogenic insults. Nonetheless, the signaling pathways induced by NMDAR inhibition are poorly understood. Here, we use complementary approaches, phosphoproteomics and tyrosine kinase profiling, to demonstrate that DXO and its derivatives rapidly regulate multiple intracellular signaling clusters, including mTOR and ERK signaling, in pancreatic islets. Notably, mTOR inhibition, but not ERK inhibition, is sufficient to negate DXO's protective effects. Further, we show that activation of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) is a universal event upon NMDAR inhibition in islets. Simultaneous knockdown of Ror1/ROR1 and its paralogue Ror2/ROR2 compromises the viability of both mouse and human islets, highlighting the ROR1/2 signaling axis as a promising avenue for enhancing beta cell survival.

molecular biology↗

bioRxiv2026

An ssRNA Phage Single-gene Lysis Protein Targeting MraY Reveals Convergent Evolution Across the RNA-DNA Phage Boundary

Small lytic phages of the ssRNA Leviviricetes and ssDNA Microviricetes achieve host lysis by expression of a single protein, designated as an Sgl protein. Four ssRNA Sgls have been shown to inhibit steps in peptidoglycan biosynthesis: three target MurJ, the Lipid II flippase, and one targets MurA, the committed step of the pathway. A fifth Sgl, the E protein of the canonical ssDNA microvirus {varphi}X174, inhibits MraY, which catalyzes the synthesis of the first lipid-linked intermediate. This inhibition requires SlyD, a cytoplasmic FKBP-type peptidyl-prolyl cis-trans isomerase. The Sgl of the Caulobacter ssRNA phage {varphi}Cb5 (Cebevirus halophobicum) has not been characterized. Here, we present physiological evidence that Sgl{varphi}Cb5 targets MraY. Moreover, we show that, despite the absence of detectable sequence similarity, Sgl{varphi}Cb5 shares several features with the {varphi}X174 E protein, including the distribution of hydrophobic and charged residues, a proposed N-out, C-in membrane topology, and retention of lytic activity in an Sgl{varphi}Cb5 -LacZ fusion. Furthermore, expression of the Caulobacter cytoplasmic FKBP-type peptidyl-prolyl cis-trans isomerase CC2799 enhances Sgl{varphi}Cb5 -mediated lysis in E. coli. These parallels between Sgl function in a DNA phage and an RNA phage either represent remarkably consonant convergent evolution or some evolutionary cross-over event for which there is currently no precedent.

molecular biology↗